1. Home
  2. BZ vs KOD Comparison

BZ vs KOD Comparison

Compare BZ & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KANZHUN LIMITED American Depository Shares

BZ

KANZHUN LIMITED American Depository Shares

HOLD

Current Price

$12.67

Market Cap

6.6B

Sector

Technology

ML Signal

HOLD

Logo Kodiak Sciences Inc

KOD

Kodiak Sciences Inc

SELL

Current Price

$100.77

Market Cap

6.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BZ
KOD
Founded
2013
2009
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
6.2B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
BZ
KOD
Price
$12.67
$100.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
7
Target Price
$20.75
★ $129.50
AVG Volume (30 Days)
★ 4.7M
785.6K
Earning Date
11-25-2026
11-12-2026
Dividend Yield
★ 1.30%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.12
N/A
Revenue Next Year
$11.83
N/A
P/E Ratio
$22.61
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.12
$18.15
52 Week High
$22.49
$112.31

Technical Indicators

Market Signals
Indicator
BZ
KOD
Relative Strength Index (RSI) 26.94 56.26
Support Level N/A $81.11
Resistance Level $14.77 $103.67
Average True Range (ATR) 0.69 6.73
MACD -0.55 -0.34
Stochastic Oscillator 8.67 50.65

Price Performance

Historical Comparison
BZ
KOD

About BZ KANZHUN LIMITED American Depository Shares

Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.

About KOD Kodiak Sciences Inc

Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.

Share on Social Networks: